GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Ltd (NSE:PFIZER) » Definitions » Institutional Ownership

Pfizer (NSE:PFIZER) Institutional Ownership : 10.32% (As of May. 22, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Pfizer Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Pfizer's institutional ownership is 10.32%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Pfizer's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Pfizer's Float Percentage Of Total Shares Outstanding is 0.00%.


Pfizer Institutional Ownership Historical Data

The historical data trend for Pfizer's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Institutional Ownership Chart

Pfizer Historical Data

The historical data trend for Pfizer can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 9.09 9.08 9.79 9.91 10.02 10.32 10.49 10.39 10.28 10.32

Pfizer Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Pfizer (NSE:PFIZER) Business Description

Traded in Other Exchanges
Address
The Capital, 1802/1901, 18th Floor, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Pfizer Ltd is a major drug manufacturing company that focuses on a global portfolio of medical products. The company works across developed and emerging markets to advance treatments through its two segments, Pfizer Innovative Health and Pfizer Essential Health. The vast majority of the company's revenue is derived from the manufacture and sale of biopharmaceutical products. most of the company's sales are generated by its Innovative Health segment. While the company operates across a wide span of international markets, most of the company's revenue is generated in India.

Pfizer (NSE:PFIZER) Headlines

No Headlines